However, there are interesting observations from the studies of cancer cells pertaining to interactions between CD44 and HA vis-à-vis the efflux pump in these cells affecting efficiency of the P-glycoprotein in removing anticancer drugs of known genotoxicity [78-81]. Here, CD44 is linked to cancer.